Literature DB >> 14761780

Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats.

Sabine Fredersdorf1, Christian Thumann, Coskun Ulucan, Daniel P Griese, Andreas Luchner, Günter A J Riegger, Eckhard P Kromer, Joachim Weil.   

Abstract

Heart failure is known to be a complication of insulin-dependent (IDDM) and noninsulin-dependent diabetes mellitus (NIDDM) even in the absence of coronary heart disease or hypertension. The mechanisms leading to diabetic cardiomyopathy are unknown. The aim of the study was to characterize structural and functional alterations in hyperinsulinemic Zucker diabetic fatty (ZDF) rats treated with or without insulin. Diabetic animals showed a twofold increase in cardiomyocyte volume with increased left ventricular ANP but not BNP mRNA levels in spite of a reduced plasma renin activity (PRA) 2 months after onset of diabetes compared to nondiabetic littermates. These changes were associated with an increase in left ventricular performance as assessed by echocardiography. Insulin treatment led to a significant increase in body weight (BW), total heart weight, myocardial protein content, and left ventricular mass (LVM). Perivascular fibrosis and laminin thickness were significantly augmented in diabetic rat myocardium irrespective of insulin treatment, whereas interstitial collagen I and fibronectin were similarly found in diabetic and control myocardium. Initial stages of diabetic cardiomyopathy in hyperinsulinemic rats are characterized by cardiomyocyte hypertrophy and enhanced cardiac contractility. It is suggested that hyperinsulinemia may be involved in cardiac hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14761780     DOI: 10.1016/S1054-8807(03)00109-1

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  38 in total

1.  Contractility of ventricular myocytes is well preserved despite altered mechanisms of Ca2+ transport and a changing pattern of mRNA in aged type 2 Zucker diabetic fatty rat heart.

Authors:  F C Howarth; M A Qureshi; Z Hassan; D Isaev; K Parekh; A John; M Oz; H Raza; E Adeghate; T E Adrian
Journal:  Mol Cell Biochem       Date:  2011-10-19       Impact factor: 3.396

2.  Exercise Training Restores the Cardiac Microrna-16 Levels Preventing Microvascular Rarefaction in Obese Zucker Rats.

Authors:  Tiago Fernandes; Lilian Casaes; Úrsula Soci; Andre Silveira; João Gomes; Diego Barretti; Fernanda Roque; Edilamar Oliveira
Journal:  Obes Facts       Date:  2018-02-07       Impact factor: 3.942

Review 3.  The Type 2 Diabetic Heart: Its Role in Exercise Intolerance and the Challenge to Find Effective Exercise Interventions.

Authors:  J Chris Baldi; Genevieve A Wilson; Luke C Wilson; Gerard T Wilkins; Regis R Lamberts
Journal:  Sports Med       Date:  2016-11       Impact factor: 11.136

4.  Cardiomyocyte contractile status is associated with differences in fibronectin and integrin interactions.

Authors:  Xin Wu; Zhe Sun; Andrea Foskett; Jerome P Trzeciakowski; Gerald A Meininger; Mariappan Muthuchamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

Review 5.  The two faces of miR-29.

Authors:  Anna Ślusarz; Lakshmi Pulakat
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2015-07       Impact factor: 2.160

6.  Increased insulin sensitivity and reduced micro and macro vascular disease induced by 2-deoxy-D-glucose during metabolic syndrome in obese JCR: LA-cp rats.

Authors:  J C Russell; S D Proctor
Journal:  Br J Pharmacol       Date:  2007-03-20       Impact factor: 8.739

7.  Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding.

Authors:  Jordan J Wright; Jaetaek Kim; Jonathan Buchanan; Sihem Boudina; Sandra Sena; Kyriaki Bakirtzi; Olesya Ilkun; Heather A Theobald; Robert C Cooksey; Kostantin V Kandror; E Dale Abel
Journal:  Cardiovasc Res       Date:  2009-01-15       Impact factor: 10.787

8.  Cardiac and renal function are progressively impaired with aging in Zucker diabetic fatty type II diabetic rats.

Authors:  John Baynes; David B Murray
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

9.  Protective effect of total aralosides of Aralia elata (Miq) Seem (TASAES) against diabetic cardiomyopathy in rats during the early stage, and possible mechanisms.

Authors:  Shugang Xi; Guihua Zhou; Xuexin Zhang; Wenjie Zhang; Lu Cai; Chunyan Zhao
Journal:  Exp Mol Med       Date:  2009-08-31       Impact factor: 8.718

Review 10.  Diabetic cardiomyopathy.

Authors:  Omar Asghar; Ahmed Al-Sunni; Kaivan Khavandi; Ali Khavandi; Sarah Withers; Adam Greenstein; Anthony M Heagerty; Rayaz A Malik
Journal:  Clin Sci (Lond)       Date:  2009-05       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.